Back to News
Market Impact: 0.12
Oracle Life Sciences, Wipro Partner On Pharmacovigilance Services
Source: Nasdaq
Healthcare & BiotechTechnology & Innovation
Oracle Life Sciences partnered with Wipro to enhance Wipro's pharmacovigilance services through Oracle's Argus business process services platform. The collaboration expands the technology-enabled drug-safety capabilities offered to life-sciences clients, but no financial terms or expected revenue impact were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
ORCL0.45
WIT0.50
More News
- The SaaS debt trap
- Microsoft cuts hundreds more jobs, shifts next ‘Halo' game to Activision in Xbox overhaul
- From $2 billion to $112 billion in annual profit: How Apple transformed its business
- FDA Accepts Insmed's Filing Seeking Label Expansion for Arikayce
- ShinyHunters claims FBI hack: 'This is NOT financially motivated'
- Trump discloses more than 1,100 July trades, including up to $25 million sales of Microsoft and Amazon
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: Unstructured Data Search, Ask AI, and Advanced Futures Data
- Best AI Stock Research Tools for Professional Investors